Emili Montserrat Selected Research

Emili Montserrat Research Topics

Disease

44	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2022 - 09/2002
13	Neoplasms (Cancer) 04/2010 - 01/2002
7	Leukemia 02/2013 - 03/2003
7	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2007 - 01/2002
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2009 - 01/2004
6	Multiple Myeloma 05/2006 - 05/2002
5	Residual Neoplasm 06/2006 - 07/2002
4	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2006 - 07/2002
3	COVID-19 01/2022 - 07/2021
3	Disease Progression 11/2011 - 11/2004
3	Hematologic Neoplasms (Hematological Malignancy) 10/2006 - 03/2003
3	Primary Myelofibrosis (Myelosclerosis) 07/2006 - 11/2004
3	Plasmacytoma 05/2006 - 05/2004
2	Necrosis 02/2014 - 05/2002
2	Chromosome Aberrations (Chromosome Abnormalities) 03/2012 - 01/2006
2	Cytopenia 07/2011 - 12/2010
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 07/2009 - 07/2002
2	Hodgkin Disease (Hodgkin's Disease) 03/2008 - 10/2007
2	Lymphoma (Lymphomas) 04/2005 - 04/2003
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2003 - 10/2002
1	Thrombosis (Thrombus) 01/2022
1	Hemorrhage 01/2022
1	Agammaglobulinemia (Hypogammaglobulinemia) 07/2021
1	Trisomy (Trisomies) 01/2016
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 09/2013
1	Hemolysis 05/2011
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2009
1	Anemia 08/2008
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2008
1	Carcinogenesis 03/2008
1	Epstein-Barr Virus Infections 03/2008
1	Sclerosis 03/2008
1	Meningioma (Meningiomas) 02/2008
1	Progressive Multifocal Leukoencephalopathy 02/2008
1	Pathologic Complete Response 02/2008
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 02/2008

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 02/2014 - 01/2002
11	fludarabineIBA 12/2013 - 09/2002
7	Mitoxantrone (Novantrone)FDA LinkGeneric 12/2013 - 09/2002
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2013 - 09/2002
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2016 - 09/2004
4	purineIBA 03/2015 - 02/2008
4	Rituximab (Mabthera)FDA Link 02/2014 - 01/2003
4	Cytarabine (Cytosar-U)FDA LinkGeneric 08/2004 - 10/2002
3	Biomarkers (Surrogate Marker)IBA 04/2017 - 03/2005
3	MicroRNAs (MicroRNA)IBA 09/2013 - 03/2008
3	LigandsIBA 11/2011 - 11/2004
3	Monoclonal AntibodiesIBA 09/2009 - 08/2003
3	DNA (Deoxyribonucleic Acid)IBA 06/2009 - 09/2004
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2008 - 09/2002
3	Etoposide (VP 16)FDA LinkGeneric 01/2008 - 10/2002
3	Thalidomide (Thalomid)FDA Link 05/2006 - 05/2004
2	Messenger RNA (mRNA)IBA 03/2022 - 11/2011
2	Oxygen (Dioxygen)IBA 01/2022 - 12/2021
2	ibrutinibIBA 01/2021 - 05/2020
2	NucleosidesIBA 12/2008 - 03/2003
2	Erythropoietin FDA Link 08/2008 - 11/2004
2	Immunoglobulins (Immunoglobulin)IBA 01/2007 - 02/2005
2	Bortezomib (Velcade)FDA Link 05/2006 - 01/2006
2	Proteasome InhibitorsIBA 05/2006 - 01/2006
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2005 - 10/2003
2	Methotrexate (Mexate)FDA LinkGeneric 08/2005 - 04/2003
2	Tumor Suppressor Protein p14ARF (p14ARF)IBA 03/2005 - 01/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2004 - 05/2002
2	Ifosfamide FDA LinkGeneric 04/2003 - 10/2002
1	COVID-19 VaccinesIBA 03/2022
1	AlbuminsIBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022
1	VaccinesIBA 07/2021
1	acalabrutinibIBA 01/2021
1	venetoclaxIBA 01/2021
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2021
1	serum P-component (CIt)IBA 01/2018
1	ofatumumab FDA Link 04/2015
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 02/2014
1	GlucocorticoidsIBA 02/2013
1	Dacarbazine (DIC)FDA LinkGeneric 03/2012
1	Blood Proteins (Serum Proteins)IBA 11/2011
1	B-Cell Activating FactorIBA 11/2011
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2011
1	forodesineIBA 08/2009
1	I-kappa B KinaseIBA 04/2009
1	NF-kappa B (NF-kB)IBA 04/2009
1	4(2'- aminoethyl)amino- 1,8- dimethylimidazo(1,2- a)quinoxalineIBA 04/2009
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 12/2008
1	CaspasesIBA 11/2008
1	Alkylating AgentsIBA 11/2008
1	Bendamustine Hydrochloride FDA Link 11/2008
1	CreatinineIBA 08/2008
1	Histones (Histone)IBA 01/2008

Therapy/Procedure

32	Therapeutics 07/2021 - 03/2003
17	Stem Cell Transplantation 05/2015 - 01/2002
6	Transplantation 12/2016 - 07/2002
6	Hematopoietic Stem Cell Transplantation 01/2016 - 04/2004
5	Drug Therapy (Chemotherapy) 09/2009 - 11/2004
2	Cell Transplantation 12/2016 - 10/2003
2	Immunotherapy 05/2011 - 10/2003
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 03/2003 - 07/2002